Ladenburg Thalmann Financial Services’s abrdn Life Sciences Investors HQL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q4
$862K Sell
49,430
-12,445
-20% -$217K 0.01% 1388
2019
Q3
$934K Buy
61,875
+13,400
+28% +$202K 0.01% 1294
2019
Q2
$818K Sell
48,475
-12,882
-21% -$217K 0.01% 1364
2019
Q1
$1.05M Buy
61,357
+5,446
+10% +$93.3K 0.01% 1158
2018
Q4
$845K Buy
55,911
+1,001
+2% +$15.1K 0.01% 1156
2018
Q3
$1.12M Sell
54,910
-1,924
-3% -$39.3K 0.01% 1053
2018
Q2
$1.09M Hold
56,834
0.01% 1019
2018
Q1
$1.09M Sell
56,834
-1,331
-2% -$25.6K 0.01% 1019
2017
Q4
$1.14M Buy
58,165
+2,448
+4% +$48.1K 0.01% 990
2017
Q3
$1.2M Buy
55,717
+2,531
+5% +$54.4K 0.01% 882
2017
Q2
$1.11M Buy
53,186
+2,230
+4% +$46.5K 0.01% 884
2017
Q1
$988K Buy
50,956
+619
+1% +$12K 0.01% 905
2016
Q4
$855K Buy
50,337
+1,931
+4% +$32.8K 0.01% 923
2016
Q3
$907K Buy
48,406
+2,215
+5% +$41.5K 0.01% 850
2016
Q2
$794K Sell
46,191
-2,933
-6% -$50.4K 0.01% 868
2016
Q1
$881K Sell
49,124
-589
-1% -$10.6K 0.02% 762
2015
Q4
$1.18M Buy
49,713
+1,005
+2% +$23.8K 0.02% 613
2015
Q3
$1.1M Buy
48,708
+32,174
+195% +$724K 0.02% 593
2015
Q2
$466K Buy
16,534
+6,082
+58% +$171K 0.01% 1084
2015
Q1
$288K Buy
10,452
+932
+10% +$25.7K 0.01% 1339
2014
Q4
$237K Buy
9,520
+2,162
+29% +$53.8K 0.01% 1310
2014
Q3
$163K Buy
7,358
+27
+0.4% +$598 ﹤0.01% 1324
2014
Q2
$152K Buy
7,331
+27
+0.4% +$560 ﹤0.01% 1349
2014
Q1
$159K Buy
7,304
+387
+6% +$8.43K ﹤0.01% 1254
2013
Q4
$141K Buy
6,917
+108
+2% +$2.2K ﹤0.01% 1253
2013
Q3
$131K Buy
6,809
+94
+1% +$1.81K ﹤0.01% 1231
2013
Q2
$120K Buy
+6,715
New +$120K ﹤0.01% 1225